comprehensive -WSS

comprehensive

author：comprehensive 2025-09-30 00:49:17 - browse：18757

Jamy Ard (left) and Robert Lustig (right) on the 2023 STAT Breakthrough Summit stage -- coverage from STAT — Obesity experts Jamy Ard (left) and Robert Lustig speak at a panel during the 2023 STAT Breakthrough Summit. Sarah Gonzalez for STAT

Amid rising demand for drugs like Wegovy, Ozempic, and Mounjaro that can lead to significant weight loss, some obesity experts are concerned about the drugs’ costs — both to patients’ finances and to their health.

Speaking at a panel on new obesity treatments at the STAT Breakthrough Summit in San Francisco on Thursday, one expert cited a large clinical trial for Wegovy that showed that about 40% of the weight participants lost was lean mass. Side effects like nausea, vomiting, and a possible link to rare cases of pancreatitis also still plague this newest class of drugs, which imitate the effects of a hormone called glucagon-like peptide 1 (GLP) that helps people feel full.

“That’s what starvation does. You lose equal amounts of muscle and fat,” said Robert Lustig, emeritus professor of pediatrics at the University of California, San Francisco. “If you’re a person 60 years old or over and you’re losing muscle, your risk of dying just went up exponentially. So we may be … robbing Peter to pay Paul.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Gain of function research would be limited under House proposal

leisure time

entertainment

Wikipedia

WSS

Childhood cancer progress stalls for Black, Hispanic kids: Report

Gain of function research would be limited under House proposal

Morphosys mixed study results for blood cancer drug

Ripples from Flovent's discontinuation is killing children with asthma

Ransomware attacks on hospitals: Study outlines patient impact

As H5N1 spreads in cows, experts warn against drinking raw milk

explore

comprehensive

Wikipedia

Duchenne breakthrough therapy leaves behind pioneering families

In key trial, Verve's treatment lowers cholesterol levels in patients

Walensky prepares to leave CDC — and Congress — behind

What a koala virus tells us about the human genome

George Santos makes 1st court appearance after pleading not guilty to 13 counts

FDA's Woodcock to retire early next year

Hollywood unions extend contract negotiations for actors

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

BioMarin wins approval for gene therapy to treat hemophilia A

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

hotspot

Wegovy, Zepbound and weight loss drugs that preserve muscle

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

CRISPR pioneers react to Casgevy, first gene

STAT reporters are Pulitzer Prize finalists for investigative reporting

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

CRISPR pioneers react to Casgevy, first gene

leisure time

entertainment

Wikipedia

focus